Jukka Hiltunen

This inventor holds 11 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Glykos Finland Oy, Map Medical Technologies Oy, Novartis International Pharmaceutical, Ltd.. Active years: 2000-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jukka Hiltunen. Retrieved from https://idiyas.com/inventor/jukka-hiltunen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 81.8

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Tikkakoski, FI (2000)
Helsinki, FI (2002 - 2021)

Company Filing History:

Map Medical Technologies Oy

patents

1 out of 29

Novartis International Pharmaceutical, Ltd.

patents

where one patent can have more than one assignee

Years Active: 2000-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988791 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2021-04-27),

2. 10724063 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2020-07-28),

3. 10724013 - O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof (2020-07-28),

4. 10544440 - Multiple protease deficient filamentous fungal cells and methods of use thereof (2020-01-28),

5. 10513724 - Production of glycoproteins with mammalian-like N-glycans in filamentous fungi (2019-12-24),

6. 10435731 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2019-10-08),

7. 9464137 - Glycoprotein (2016-10-11),

8. 9399764 - Fusion enzymes (2016-07-26),

9. 9320291 - Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells (2016-04-26),

10. 6365125 - Process for the production of radioiodinated neuroreceptor agents (2002-04-02),

11. 6015544 - Process for producing radiolabelled benzodiazepine receptor agents and (2000-01-18),

Title: Jukka Hiltunen: Innovator in Filamentous Fungal Cell Technology

Introduction

Jukka Hiltunen is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of filamentous fungal cells for protein production. With a total of 11 patents to his name, Hiltunen's work has advanced the understanding and application of genetic modifications in fungi.

Latest Patents

Hiltunen's latest patents include innovative methods and compositions for producing heterologous proteins in filamentous fungal cells. One notable patent is focused on multiple proteases deficient filamentous fungal cells, which enhances the production of proteins by reducing protease activity. Another significant patent involves O-mannosyltransferase deficient filamentous fungal cells, which allows for the production of proteins with reduced O-mannosylation. These inventions represent a leap forward in the efficiency and effectiveness of protein production in biotechnological applications.

Career Highlights

Throughout his career, Jukka Hiltunen has worked with various companies, including Glykos Finland Oy and Map Medical Technologies Oy. His expertise in genetic engineering and protein production has made him a valuable asset in the biotechnology sector. Hiltunen's innovative approaches have not only led to numerous patents but have also contributed to advancements in the industry.

Collaborations

Hiltunen has collaborated with notable professionals in his field, including Anne Huuskonen and Markku Saloheimo. These collaborations have fostered a productive environment for innovation and have furthered the development of his patented technologies.

Conclusion

Jukka Hiltunen's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor in filamentous fungal cell technology. His work continues to influence the production of heterologous proteins, paving the way for future advancements in the industry.

Profile summary based on public USPTO records.